| | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| Recipharm invests €1.2m in Italian small-scale API capabilities "The second one is a multi-purpose plant which manufactures various APIs, including anaesthetics, NSAIDs, anti-diabetes drugs, CNS drugs, ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.